analyst
AR
NASDAQ · ARWR
Arrowhead Pharmaceuticals, Inc.
Healthcare · Biotechnology
$65.46
Up+$0.79 (+1.21%)
Updated Sep 29, 2026, 10:58 PM
SID Score
4.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 8.86B
- P/E ratio
- 43.81
- Dividend yield
- 0.00%
- 52-week range
- $34.47 – $95.49
- Volume
- 1.59M
- Avg. volume
- 3.18M
Price performance · ARWR
ARWR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 28, 2026
ARWR closed at $65.46 after 20 trading sessions, down 20.55% for the selected period.
- Last close
- $65.46
- Period change
- -20.55%
- Period low
- $65.46
- Period high
- $86.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 28, 2026 | $65.00 | $66.1133 | $63.99 | $65.46 | 1.59M |
| Sep 25, 2026 | $66.50 | $67.4381 | $65.40 | $65.92 | 1.62M |
| Sep 24, 2026 | $67.00 | $67.45 | $65.46 | $66.07 | 1.63M |
| Sep 23, 2026 | $72.155 | $72.49 | $66.27 | $66.96 | 2.56M |
| Sep 22, 2026 | $68.85 | $72.365 | $68.08 | $71.86 | 3.12M |
| Sep 21, 2026 | $67.455 | $69.26 | $66.06 | $68.79 | 2.35M |
| Sep 18, 2026 | $67.83 | $68.05 | $66.36 | $66.48 | 4.02M |
| Sep 17, 2026 | $68.91 | $68.91 | $66.995 | $67.74 | 3.21M |
| Sep 16, 2026 | $70.41 | $71.9283 | $64.50 | $65.79 | 5.11M |
| Sep 15, 2026 | $82.89 | $83.55 | $70.605 | $70.67 | 4.37M |
| Sep 14, 2026 | $82.98 | $83.27 | $79.93 | $80.67 | 1.33M |
| Sep 11, 2026 | $83.75 | $85.98 | $82.355 | $82.85 | 1.34M |
| Sep 10, 2026 | $81.58 | $83.38 | $80.33 | $82.76 | 1.02M |
| Sep 9, 2026 | $84.65 | $87.20 | $82.16 | $82.63 | 3.67M |
| Sep 8, 2026 | $84.22 | $86.96 | $83.54 | $85.11 | 1.57M |
| Sep 4, 2026 | $85.87 | $86.96 | $84.2042 | $86.34 | 757.85K |
| Sep 3, 2026 | $85.18 | $86.79 | $83.46 | $86.49 | 1.37M |
| Sep 2, 2026 | $82.87 | $85.47 | $82.085 | $85.37 | 1.53M |
| Sep 1, 2026 | $81.14 | $83.27 | $80.76 | $82.74 | 1.33M |
| Aug 31, 2026 | $83.13 | $83.7554 | $80.75 | $82.39 | 1.6M |
Latest ARWR news
The latest Smart Investors Daily articles mentioning ARWR.
Stock researchResearch & News · SEC Filings
Company
OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials
Market Activity
OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment
Research & News
Loading stock research…